Committee members were drawn largely from academic institutions and medical centers and had expertise in medicine, nursing, health policy and management, pharmacy, and social work. There were also representatives from the American Association of Colleges of Pharmacy, Robert Wood Johnson Foundation, and National Center for Healthcare Leadership; a 13-member panel that reviewed the report was similarly constituted, with one representative from Pfizer Inc.